4.5 Article

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens

Journal

GENOME BIOLOGY
Volume 15, Issue 12, Pages -

Publisher

BMC
DOI: 10.1186/s13059-014-0554-4

Keywords

-

Funding

  1. NIH [R01 GM099409]
  2. Claudia Adams Barr Award in Innovative Basic Cancer Research from the Dana-Farber Cancer Institute
  3. NATIONAL CANCER INSTITUTE [T32CA009337] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099409] Funding Source: NIH RePORTER

Ask authors/readers for more resources

We propose the Model-based Analysis of Genome-wide CRISPR/Cas9 Knockout (MAGeCK) method for prioritizing single-guide RNAs, genes and pathways in genome-scale CRISPR/Cas9 knockout screens. MAGeCK demonstrates better performance compared with existing methods, identifies both positively- and negatively-selected genes simultaneously, and reports robust results across different experimental conditions. Using public datasets, MAGeCK identified novel essential genes and pathways, including EGFR in vemurafenib treated A375 cells harboring a BRAF mutation. MAGeCK also detected cell-type specific essential genes including BCR and ABL1 in the KBM7 cells bearing a BCR-ABL fusion, and IGF1R in the HL-60 cells, which depends on the insulin signaling pathway for proliferation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available